Notice: This company has been marked as potentially delisted and may not be actively trading. IVERIC bio (OPHT) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Gossamer Bio Inc GOSSNovember 5, 2023 | morningstar.comIveric Bio ticks higher as it sees sale to Astellas closing July 11June 30, 2023 | msn.comIveric Bio falls amid concern about Astellas dealJune 29, 2023 | msn.comBaird Downgrades IVERIC bio (ISEE)May 6, 2023 | msn.comApellis Pharmaceuticals: Maintain 'Buy' Following Astellas' $5.9 Billion Acquisition Of Iveric BioMay 6, 2023 | msn.comIveric Bio (NASDAQ:ISEE) Sold for $5.9BMay 2, 2023 | msn.comAstellas to Buy Eye-Drug Maker Iveric Bio for $5.9 BillionMay 1, 2023 | msn.comAstellas Pharma buys Iveric Bio for $5.9 billionMay 1, 2023 | reuters.comAstellas Pharma to Buy Iveric Bio for $5.9 BillionApril 30, 2023 | msn.comAstellas Pharma to Buy Iveric Bio for About $5.9BApril 30, 2023 | wsj.comAstellas Pharma agrees to buy Iveric Bio for $5.9 BillionApril 30, 2023 | msn.comRobert W. Baird Keeps Their Buy Rating on Iovance Biotherapeutics (IOVA)March 3, 2023 | markets.businessinsider.comIVERIC Bio Shares Up 14% After Positive Trial Results, 4Q LossesMarch 1, 2023 | marketwatch.comIveric Bio Shares Rise 16% After FDA Accepts New Drug App for Avacincaptad PegolFebruary 17, 2023 | marketwatch.comDeep Track Capital Now Owns 5.88% of IVERIC bio (ISEE)February 16, 2023 | nasdaq.comRtw Investments Now Owns 0.60% of IVERIC bio (ISEE)February 16, 2023 | nasdaq.comISEE IVERIC bio, Inc.September 16, 2022 | seekingalpha.comWhere IVERIC bio Stands With AnalystsSeptember 7, 2022 | markets.businessinsider.comIveric Bio To Announce GATHER2 Trial Data In SeptemberAugust 25, 2022 | markets.businessinsider.comWhy Ophthotech (OPHT) Stock Is Surging TodayJanuary 18, 2022 | thestreet.comIVERIC bio, Inc. 2021 Q2 - Results - Earnings Call PresentationAugust 9, 2021 | seekingalpha.com Get IVERIC bio News Delivered to You Automatically Sign up to receive the latest news and ratings for OPHT and its competitors with MarketBeat's FREE daily newsletter. Email Address OPHT Media Mentions By Week OPHT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPHT News Sentiment▼0.000.57▲Average Medical News Sentiment OPHT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPHT Articles This Week▼00▲OPHT Articles Average Week Get IVERIC bio News Delivered to You Automatically Sign up to receive the latest news and ratings for OPHT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MDGL News Today BBIO News Today LEGN News Today ELAN News Today CORT News Today TLX News Today CYTK News Today NUVL News Today GRFS News Today IONS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPHT) was last updated on 1/21/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IVERIC bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IVERIC bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OPHT Stock Alerts